Merck Questioned over Vioxx Marketing
home > metasearch
WASHINGTON -- Merck & Co.'s internal documents about the marketing of the Vioxx painkiller suggest the company may have downplayed the heart risk that later caused the drug's withdrawal, the U.S. House Committee of Government Reform said. The committee will...
- link to Merck Questioned over Vioxx Marketing -
Last update: 06/01/2005